Mack R - Search Results

1

Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine.

Ramanathan S, Kakuda TN, Mack R, West S, Kearney BP. Ramanathan S, et al. Among authors: mack r. Antivir Ther. 2008;13(8):1011-7. Antivir Ther. 2008. PMID: 19195326 Clinical Trial.

2

Effect of ritonavir-boosted tipranavir or darunavir on the steady-state pharmacokinetics of elvitegravir.

Mathias AA, Hinkle J, Shen G, Enejosa J, Piliero PJ, Sekar V, Mack R, Tomaka F, Kearney BP. Mathias AA, et al. Among authors: mack r. J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):156-62. doi: 10.1097/QAI.0b013e318183a982. J Acquir Immune Defic Syndr. 2008. PMID: 18769354 Clinical Trial.

3

Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials.

Kakuda TN, Abel S, Davis J, Hamlin J, Schöller-Gyüre M, Mack R, Ndongo N, Petit W, Ridgway C, Sekar V, Tweedy S, Hoetelmans RM. Kakuda TN, et al. Among authors: mack r. Antimicrob Agents Chemother. 2011 May;55(5):2290-6. doi: 10.1128/AAC.01046-10. Epub 2011 Mar 7. Antimicrob Agents Chemother. 2011. PMID: 21383098 Free PMC article. Clinical Trial.

4

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents.

Königs C, Feiterna-Sperling C, Esposito S, Viscoli C, Rosso R, Kakuda TN, Leemans R, Peeters M, Mack R, Peeters I, Sinha R, Boven K, Giaquinto C. Königs C, et al. Among authors: mack r. AIDS. 2012 Feb 20;26(4):447-55. doi: 10.1097/QAD.0b013e32834f30b1. AIDS. 2012. PMID: 22156961 Clinical Trial.

5

Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial.

Cohen CJ, Berger DS, Blick G, Grossman HA, Jayaweera DT, Shalit P, Thompson M, Peeters M, de Béthune MP, Voorspoels E, Mack R, Woodfall B. Cohen CJ, et al. Among authors: mack r. AIDS. 2009 Jan 28;23(3):423-6. doi: 10.1097/QAD.0b013e32831c5040. AIDS. 2009. PMID: 19114852 Clinical Trial.

6

Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.

Chen CL, Orr WC, Verlinden MH, Dettmer A, Brinkhoff H, Riff D, Schwartz S, Soloway RD, Krause R, Lanza F, Mack RJ. Chen CL, et al. Among authors: mack rj. Aliment Pharmacol Ther. 2002 Apr;16(4):749-57. doi: 10.1046/j.1365-2036.2002.01218.x. Aliment Pharmacol Ther. 2002. PMID: 11929393 Clinical Trial.

7

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.

Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Talley NJ, et al. Among authors: mack rj. Aliment Pharmacol Ther. 2000 Dec;14(12):1653-61. doi: 10.1046/j.1365-2036.2000.00868.x. Aliment Pharmacol Ther. 2000. PMID: 11121915 Clinical Trial.

8

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.

Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Talley NJ, et al. Among authors: mack rj. Gut. 2001 Sep;49(3):395-401. doi: 10.1136/gut.49.3.395. Gut. 2001. PMID: 11511562 Free PMC article. Clinical Trial.

9

The St. Jude Global Academy: A Multifaceted Education Program to Expand Pediatric Oncology Workforce Capacity.

Moreira DC, Hashmi SK, Andujar A, Berg F, Conger K, Fox Irwin L, Mikkelsen M, Antillón-Klussmann F, Bazzeh F, Cypriano M, Gao YJ, González-Ramella O, Rivas S, Lopes LF, Mack R, Morosini F, Noun D, Garcia X, Homsi MR, Puerto-Torres M, Agulnik A, Baker JN, Caniza MA, McNeil MJ, Qaddoumi I, Chantada G, Rodríguez-Galindo C. Moreira DC, et al. Among authors: mack r. Pediatr Blood Cancer. 2025 Jan 5:e31499. doi: 10.1002/pbc.31499. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 39757452

10

Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala.

Moreira DC, Garrido C, Rosado R, Girón V, Letona T, Morales G, Valverde P, Velásquez T, Alfaro J, Orellana E, Ortega MA, Salguero P, Fox Irwin L, Andujar A, de Alarcón PA, Luna-Fineman S, Manco-Johnson M, Conter V, Verna M, Canesi M, Massimino M, Spreafico F, Ferrari A, Gassant PY, Vásquez R, Friedrich P, Mack R, Ribeiro R, Metzger ML, Rodriguez-Galindo C, Antillón-Klussmann F. Moreira DC, et al. Among authors: mack r. JCO Glob Oncol. 2024 Jun;10:e2300474. doi: 10.1200/GO.23.00474. JCO Glob Oncol. 2024. PMID: 38870436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters